PURE Bioscience, Inc. (PURE) Free cash flow 2016–2024
PURE Bioscience, Inc. (PURE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$2.6MFY2024 · since FY2016: -$5.1M → -$2.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$2.6M | +23.7% |
| FY2023 | -$3.4M | -14.3% |
| FY2022 | -$2.9M | -139.9% |
| FY2021 | -$1.2M | -285.0% |
| FY2020 | $662,000 | +122.0% |
| FY2019 | -$3.0M | +26.5% |
| FY2018 | -$4.1M | +17.3% |
| FY2017 | -$5.0M | +2.4% |
| FY2016 | -$5.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice